Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters.

Jia, Qingmei; Bielefeldt-Ohmann, Helle; Maison, Rachel M; Maslesa-Galic, Sasa; Cooper, Sarah K; Bowen, Richard A; Horwitz, Marcus A

Jia, Qingmei; Bielefeldt-Ohmann, Helle; Maison, Rachel M; Maslesa-Galic, Sasa; Cooper, Sarah K; Bowen, Richard A; Horwitz, Marcus A.

Afiliação

Jia Q; Division of Infectious Diseases, Department of Medicine, 37-121 Center for Health Sciences, School of Medicine, University of California - Los Angeles, Los Angeles, CA, USA.
Bielefeldt-Ohmann H; School of Veterinary Science, University of Queensland, Brisbane, QLD, Australia.
Maison RM; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Maslesa-Galic S; Division of Infectious Diseases, Department of Medicine, 37-121 Center for Health Sciences, School of Medicine, University of California - Los Angeles, Los Angeles, CA, USA.
Cooper SK; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA.
Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, USA.
Horwitz MA; Division of Infectious Diseases, Department of Medicine, 37-121 Center for Health Sciences, School of Medicine, University of California - Los Angeles, Los Angeles, CA, USA. MHorwitz@mednet.ucla.edu.

NPJ Vaccines ; 6(1): 47, 2021 Mar 30.

Article em En | MEDLINE | ID: mdl-33785745

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google